Enkephalin constrains fear learning via volume transmission to the lateral amygdala

Fear is a vital survival tool. It allows an animal to learn that a specific sound, smell, or sight predicts danger, prompting a quick escape or a freeze response. However, this learning mechanism must be precise. If the brain learns too quickly or too broadly, a harmless noise could trigger a paralyzing panic, or a single bad experience could generalize to make the entire world feel threatening. This kind of excessive or generalized fear is a hallmark of anxiety disorders and trauma-related conditions. For decades, scientists have understood that a chemical called dopamine acts as a teacher in the brain's fear center, strengthening the connection between a cue and a threat. But for fear to remain adaptive, there must be a counterbalance—a brake that prevents the learning from becoming too intense. Until now, the exact location and mechanism of this brake have remained a mystery.

A new study from researchers at the University of Sydney and collaborating institutions has identified this braking system. They discovered that a specific region of the brain, sitting right at the border between the fear center and the movement control center, releases a natural pain-relieving chemical called met-enkephalin. This chemical does not travel along a direct wire to its target; instead, it drifts through the fluid-filled spaces between brain cells to reach the fear center. Once there, it dampens the release of dopamine, effectively turning down the volume on fear learning. This process ensures that the brain learns to fear threats without becoming overwhelmed by them.

The researchers focused their investigation on a small area called the amygdalo-striatal transition zone, or ASt. This region sits immediately next to the lateral amygdala, the part of the brain responsible for forming fear memories. While the lateral amygdala is known to be rich in dopamine receptors, it contains very little of the natural opioid chemicals that the body produces to regulate pain and stress. The ASt, however, is packed with neurons that produce met-enkephalin. The team wanted to know if this nearby region was the source of the opioid signals that had been observed in the fear center during learning, and if so, how it communicated with the fear center.

To find out, the scientists used rats trained to associate a specific 60-second tone with a mild, harmless foot shock. As the rats learned that the tone predicted the shock, the researchers monitored the chemical activity in their brains. They found that at the very beginning of training, when the rats did not yet know what the tone meant, the brain released met-enkephalin only when the shock actually happened. But as the rats learned that the tone was a warning, the release of met-enkephalin shifted. The chemical began to appear when the tone played, even before the shock occurred. This shift showed that the brain was using this chemical not just to react to pain, but to anticipate and regulate the learning process itself.

The team then traced the origin of this signal. They confirmed that the met-enkephalin was not being made inside the fear center itself, but was being released by neurons in the neighboring ASt. These neurons receive strong, direct input from the auditory thalamus, the part of the brain that processes sound. When the researchers stimulated the auditory pathways, they saw a robust release of met-enkephalin from the ASt. Crucially, they observed that this chemical signal was larger and appeared faster in the ASt than in the adjacent fear center. The signal in the fear center was smaller and arrived slightly later, a pattern consistent with a substance drifting through the extracellular fluid rather than being fired across a direct synaptic connection. This mode of travel is known as volume transmission, where chemicals spread out to influence a wide area rather than a single specific target.

To prove that this drifting chemical was actually controlling fear learning, the researchers used a genetic tool to reduce the amount of met-enkephalin produced specifically in the ASt. They then tested the animals in a learning task designed to measure how easily new fears are formed. In a normal brain, if an animal has already learned that one cue predicts a shock, it is harder for it to learn that a second, new cue predicts the same shock; the brain essentially blocks the new learning because the outcome is already predicted. However, in the animals with reduced met-enkephalin in the ASt, this blocking effect disappeared. They learned the association with the new cue much faster and more strongly than the control animals. This result demonstrated that the natural release of met-enkephalin from the ASt normally acts as a constraint, limiting the speed and intensity of fear learning to prevent it from becoming excessive.

The study also revealed how this chemical brake works on a molecular level. The researchers found that met-enkephalin suppresses the release of dopamine in both the ASt and the fear center. Dopamine is the chemical that drives the strengthening of fear memories; by reducing dopamine, met-enkephalin effectively lowers the "gain" on the learning system. They showed that this suppression happens through specific receptors on the dopamine-releasing nerve terminals. When met-enkephalin binds to these receptors, it stops the dopamine from being released. This mechanism is direct and local, occurring right where the learning happens.

The findings suggest that the ASt acts as a sophisticated control hub. It receives sensory information about sounds and other stimuli, and in response, it releases met-enkephalin. This chemical then spreads to the fear center, where it checks the flow of dopamine. By doing so, it ensures that fear associations are formed only when necessary and are not allowed to become too strong or too generalized. The study indicates that this system is dynamic, shifting its activity from the actual threat to the warning signal as learning progresses. If this system is disrupted, perhaps by chronic stress or drug use, the brain may lose its ability to regulate fear, potentially leading to the overgeneralized anxiety seen in psychiatric conditions. The research provides a clear, physical explanation for how the brain balances the need to learn from danger with the need to remain calm in the face of the unknown.